- Home
- SST vs ICCM Comparison
SST vs ICCM Comparison
Compare SST & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SST | ICCM |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.7M | 45.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SST | ICCM |
|---|---|---|
| Price | $4.23 | $0.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $10.00 | $2.50 |
| AVG Volume (30 Days) | 30.1K | ★ 368.6K |
| Earning Date | 11-05-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $289,784,000.00 | $2,975,000.00 |
| Revenue This Year | N/A | $13.67 |
| Revenue Next Year | N/A | $38.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.90 | $0.59 |
| 52 Week High | $15.00 | $1.66 |
Technical Indicators
Market Signals| Indicator | SST | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 50.71 | 42.40 |
| Support Level | $4.10 | $0.67 |
| Resistance Level | $5.00 | $0.72 |
| Average True Range (ATR) | 0.45 | 0.04 |
| MACD | 0.19 | 0.01 |
| Stochastic Oscillator | 59.91 | 64.77 |
Price Performance
Historical ComparisonAbout SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.